Literature DB >> 10147128

Evaluating IV drug delivery systems.

J Garrelts1.   

Abstract

Mesh：

Year:  1993        PMID： 10147128     DOI： 10.2165/00019053-199303030-00008

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  12 in total

1.  Model for evaluating costs associated with i.v. drug delivery systems.

Authors:  K H Kappeler; S W Birdwell; D J Scheckelhoff; C H Reilly
Journal:  Am J Hosp Pharm       Date:  1992-06

2.  Cost considerations of conversion from aminoglycoside-containing combination regimens to ceftriaxone.

Authors:  L L Briceland; W R Outman; C H Nightingale; R Quintiliani
Journal:  DICP       Date:  1991-03

Review 3.  A critical reevaluation of the "therapeutic range" of aminoglycosides.

Authors:  J P McCormack; P J Jewesson
Journal:  Clin Infect Dis       Date:  1992-01       Impact factor: 9.079

4.  Attitudes of house physicians concerning various antibiotic-use control programs.

Authors:  M D Murray; R B Kohler; M C McCarthy; J W Main
Journal:  Am J Hosp Pharm       Date:  1988-03

5.  Comparative cost effectiveness of gentamicin and tobramycin.

Authors:  J J Holloway; C R Smith; R D Moore; E R Feroli; P S Lietman
Journal:  Ann Intern Med       Date:  1984-12       Impact factor: 25.391

6.  Effect of aminoglycoside-use restrictions on drug cost.

Authors:  O H DeTorres; R E White
Journal:  Am J Hosp Pharm       Date:  1984-06

7.  What is the cost of nephrotoxicity associated with aminoglycosides?

Authors:  J M Eisenberg; H Koffer; H A Glick; M L Connell; L E Loss; G H Talbot; N H Shusterman; B L Strom
Journal:  Ann Intern Med       Date:  1987-12       Impact factor: 25.391

Review 8.  The aminoglycosides.

Authors:  R S Edson; C L Terrell
Journal:  Mayo Clin Proc       Date:  1991-11       Impact factor: 7.616

9.  Cost savings associated with use of gentamicin versus tobramycin.

Authors:  T L Schwinghammer; M J Romano; E J Wing
Journal:  Am J Hosp Pharm       Date:  1985-08

10.  Serum level monitoring of aminoglycoside antibiotics. Limitations in intensive care unit-related bacterial pneumonia.

Authors:  L M Flint; J Gott; L Short; J D Richardson; H C Polk
Journal:  Arch Surg       Date:  1985-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.